• Tobias S Köhler, Robert A Kloner, Raymond C Rosen, Arthur L Burnett, Michael J Blaha, Peter Ganz, Irwin Goldstein, Noel N Kim, Tom Lue, Kevin T McVary, John P Mulhall, Sharon J Parish, Hossein Sadeghi-Nejad, Richard Sadovsky, Ira D Sharlip, and Martin Miner.
• Department of Urology, Mayo Clinic, Rochester, MN. Electronic address: kohler.tobias@mayo.edu.
• Mayo Clin. Proc. 2024 Sep 1; 99 (9): 150015171500-1517.

AbstractThe Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative symposium dedicated to optimizing sexual function and preserving cardiovascular health. The Fourth Princeton Consensus Conference was convened on March 10-11, 2023, at the Huntington Medical Research Institutes in Pasadena, California. Princeton panels I to III addressed the clinical management of men with erectile dysfunction (ED) who also had cardiovascular disease. Thirteen years since Princeton III, Princeton IV builds on previous foundations in several key areas. Mounting evidence supports the need for providers to treat men with ED as being at risk for cardiac events until proven otherwise. Algorithms for the diagnosis and treatment of ED are updated with new recommendations for coronary artery calcium scoring for advanced cardiovascular risk stratification. Optimization of oral phosphodiesterase type 5 inhibitors in the treatment of men with ED and cardiovascular disease is thoroughly explored, including recent evidence of potential cardioprotective effects of these drugs.Copyright © 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

31 keywords...

hide…